Brooks Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.3 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Brooks Laboratories Limited has submitted its financial results for the quarter and half-year ended September 30, 2025 to the NSE. The filing covers Q2 FY2026 and H1 FY2026 results. No specific revenue, profit, or margin figures are mentioned in this intimation notice itself — those would be in the detailed results document. This is a standard regulatory compliance filing confirming the results have been filed within the required timeline.
Neutral in the short term — this is a procedural filing. The actual stock reaction will depend on the numbers in the detailed results, which investors should review separately for revenue trends, profit growth, and margin performance.